Delivery Order SPE2DB22D3011-SPE2DB25FP9PA
Award Date
2/27/25
Potential Completion Date
2/28/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.78 firm fixed-price delivery order contract is for the supply of Mesalamine delayed-release tablets (1.2 gram, 120 count), with a completion date of January 20, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of mesalamine delayed-release tablets. The $10,894.56 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,780.06 Firm Fixed Price Delivery Order contract is for the supply of 4566844175 Mesalamine DR 1.2 GM Tablet 120S, with a performance period ending on January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,797.58 firm fixed-price delivery order is for Mesalamine 800 mg delayed-release tablets and has a completion date of February 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.36 firm-fixed-price delivery order is for the supply of 120 tablets of Mesalamine DR 1.2 GM, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of February 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,260.78 firm-fixed-price delivery order is for the supply of 120 tablets of 1.2 gram Mesalamine delayed-release tablets. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,569.90, is for the delivery of 4,565,597,427 tablets of Mesalamine delayed-release 1.2 gram tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 28, 2024. Amerisourcebergen has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs)...
This federal contract award, valued at $11,399.11, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,563,248,393 units of MESALAMINE 800 MG DR TABLET 180S, with an ultimate completion date of January 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,226.47 fixed-price delivery order is for the supply of 4,565,481,647 units of the medication Mesalamine DR 1.2 GM Tablet, with a performance period ending on August 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,379,229 units of the drug Mesalamine DR 1.2 GM Tablet 120S. The contract has a total ceiling value of $4,158.84 and is a Firm Fixed Price Delivery Order contract running through February 26, 2025. There was no set-aside designation associated with this award. AmerisourceBergen holds a significant $999,999,999 Indefinite...